tiprankstipranks
Advertisement
Advertisement

ANI Pharmaceuticals sees FY24 adjusted EPS, revenue ‘at or above’ guidance

ANI previously forecast FY24 adjusted EPS $4.90-$5.05, consensus $5.02, and FY24 revenue $594M-$602M, consensus $598.67M.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1